Lynne: Recognizing Inflammation and Comorbidities Associated with AD
Launch Date:
December 23, 2020
Expiration Date:
December 22, 2021
primary audience:
Dermatologists, Nurse practitioners (nps), Pediatric dermatologists, Physician assistants (pas), Primary care physicians
Relevant Terms:
Atopic dermatitis, Comorbidities, Quality of life, Systemic therapy, Type 2 inflammation
Brad P. Glick, DO, MPH, FAAD, FAOCD
Dr. Brad Glick is a board certified dermatologist and dermatologic surgeon with clinical and academic practices in South Florida. He is the Director of the Dermatology Residency at the Larkin Hospital, Palm Springs and Clinical Assistant Professor of Dermatology at the Herbert Wertheim College of Medicine Miami, Florida. Dr. Glick is also Director, and Principal Investigator for GSI Clinical Research in Margate, Florida as well as the current Vice President for the Florida Society for Dermatology and Dermatologic Surgery.
Dr. Glick’s Dermatology residency training was performed at the Greater Miami Skin and Laser Center at Mount Sinai Medical Center, Miami Beach, Florida where he earned certificates in Dermatologic, Mohs Micrographic, and Laser Surgery.
He is a Diplomate of the American Osteopathic Board of Dermatology, American Osteopathic Board of Family Practice, and National Board of Osteopathic Medical Examiners. Dr. Glick has also served as past President of the American Osteopathic College of Dermatology (AOCD), President of the Foundation for Osteopathic Dermatology (FOD), and past President of the Broward County Dermatologic Society.
Elizabeth Swanson, MD, FAAD
Dr. Swanson is a board-certified dermatologist and pediatric dermatologist. She was born in New Orleans, Louisiana, and raised in Scottsdale, Arizona. She attended college at the University of Colorado at Boulder, graduating with honors as an English major. After that she obtained her medical degree from Tulane University School of Medicine in New Orleans. She performed her internship at Mayo Clinic in Scottsdale, Arizona, and went on to complete her dermatology residency at Mayo Clinic in Rochester, Minnesota. After that, she completed a fellowship in Pediatric Dermatology at Phoenix Children’s Hospital in Arizona. She was in private practice in Colorado from 2011 through 2020. She moved to Boise, Idaho in summer 2020 to become the first and only pediatric dermatologist in the state of Idaho.
She served as Treasurer, Vice President and President of the Colorado Dermatological Society. She was a member of the Legislative Council for the Colorado Medical Society from 2016 through 2020. She is an active lecturer at conferences discussing pediatric dermatology with audiences across the country. She has been selected as a “Top Doc” by 5280 Magazine every year from 2012 through 2020. She is on staff at St Luke’s Children’s Hospital where she sees hospital consults and performs procedures.
Program Overview
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by intense itching and recurrent eczematous lesions. The disease affects up to 20% of children and up to 3% of adults. AD usually starts in childhood, and may represent the cutaneous manifestation of an “atopic march” in which most patients also develop asthma and allergic rhinitis.
AD has a tremendous negative impact on the quality of life of both patients and their families. The disease is associated with several comorbidities, including mental health disorders (depression, anxiety, autism, ADHD), hypertension, obesity, infections, osteoporosis, fractures, vitiligo, alopecia areata, visual problems, and dental issues. Patients are more accident-prone Sleep disturbances are common, and persist even during periods of remission.
This online curriculum will examine the clinical characteristics, the current immuno-pathophysiology, and the psychosocial and quality of life impact of AD on patients across age groups, and provide strategies to individualize treatment for patients with atopic dermatitis.
ACCME Accreditation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The National Association for Continuing Education designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP Approval
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hour(s).
Disclosure of Commercial Support
This educational activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Course Directors
Brad P. Glick, DO, MPH, FAAD, FAOCD
Program Director, Dermatology Residency
Larkin Community Hospital Palm Springs
Deputy Chair, Individual Giving Committee, AAD
Vice President, Florida Society for Dermatology and Dermatologic Surgery
Clinical Assistant Professor of Dermatology
Herbert Wertheim College of Medicine
Miami, Florida
Elizabeth (Lisa) Swanson, MD
Ada West Dermatology
St Luke’s Children’s Hospital
Boise, ID
Medical Writer:
Joshua Kilbridge, Medical Writer
Disclosure of Unlabeled/Investigational Uses of Products
The content of the presentations may include discussion of unapproved or investigational uses of product or devices.
Policy on Faculty and Provider Disclosure
Educational programs sponsored by the National Association for Continuing Education (NACE) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a NACE-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. Any potential conflicts of interest will be resolved prior to the activity.
Per the ACCME, a Commercial Interest is defined as an entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on, patients. Providers of clinical service directly to patients are not considered to be commercial interests – unless the provider of the clinical service is owned, or controlled by, a defined commercial interest.
Faculty disclosures are provided below:
Individual Disclosure Statements
Brad Glick, DO has disclosed the following financial relationships: :
- Investigator: AbbVie, Celgene, ChemoCentryx, Dermira, and Sun Pharma.
- Advisory Board Member: AbbVie, Celgene, Dermavant, Dermira, Genzyme, Lilly Novartis, Ortho Dermatologics, Pfizer, Sanofi, and Sun Pharma.
- Speaker/Teaching: AbbVie, Celgene, Dermira, Lilly, Ortho Dermatologics, Novartis, Pfizer, and Sun Pharma.
Elizabeth (Lisa) Swanson, MD has disclosed the following financial relationships:
- Advisory Board Member: Sanofi Regeneron, Janssen, Lilly, Ortho Dermatologics, Cassiopea
- Speakers Bureau: Ortho Dermatologics, Pfizer, Amgen, Sanofi Regneron, Almirall, Janssen, Lilly
- Speaking/Teaching: Ortho Dermatologics, Pfizer, Amgen, Sanofi Regneron, Almirall, Janssen, Lilly
Planning Committee
Gregg Sherman, MD, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.
Laurl Ann Matey, MSN, RN, CHPN, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.
Angela Golden, DNP, FNP-C, FAANP, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.
Michelle Frisch, MPH, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.
Sheila Lucas, CWEP, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.
Joshua Kilbridge, Medical Writer, has no relevant conflicts of interest with any ACCME-defined commercial interest.
How to claim credit
1. Read the learning objectives and faculty disclosures.
2. Participate in the activity.
3. Complete the post-test and activity evaluation.
4. Physicians who successfully complete the post-test and evaluation will receive CME credit.
5. Nurse Practitioners who successfully complete the post-test and evaluation will receive AANP CE credit.
6. You must score 70% or higher on the post-test to receive credit for this activity.
7. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
Course format/medium: Internet CME Activity
Estimated time to complete the activity: 15 minutes
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003,
Vista, XP, Windows 7, Windows 8 and above
Google Chrome 28.0+ for Windows, Mac OS, or
Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above
For video playback, install the latest version of Flash
or Quicktime.
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Related Courses
Making A Difference for Your AD Patients: Patient-Centric Strategies t...
ACCREDITATION STATEMENTThis activity has been planned and implemented in accordance with the accred...
Launches:
Jan 31, 2022
Expires:
Jan 31, 2023
Dan: Optimizing Care for Atopic Dermatitis
Program Overview Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by inte...
Launches:
Dec 23, 2020
Expires:
Dec 22, 2021
Pustular Psoriasis: Recognizing and Treating A Rare But Serious Diseas...
PROGRAM DESCRIPTION Pustular psoriasis is a group of rare psoriasis subtypes typified by aseptic, ne...
Launches:
Jul 12, 2021
Expires:
Jul 12, 2022
